The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Modifiable metabolic markers c-peptide (C-PEP), highly sensitive c-reactive protein (hsCRP), leptin (LEP)] and lung cancer (LC) risk: A matched case-control study nested in the prostate, lung, colorectal and ovarian (PLCO) cancer screening study.
 
Pamela Jean Goodwin
No Relationships to Disclose
 
Martin Tammemagi
No Relationships to Disclose
 
Vuk Stambolic
No Relationships to Disclose
 
Ryan JO Dowling
No Relationships to Disclose
 
Craig Williams
No Relationships to Disclose
 
Matt Moore
No Relationships to Disclose
 
Ana Elisa Lohmann
No Relationships to Disclose
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Merck/Schering Plough; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Lilly
Research Funding - Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - Novartis